Tag: Acadia Healthcare

US FDA Approves Rett Syndrome Drug by Acadia

Sandy B

The US FDA granted Acadia Pharmaceuticals’ DAYBUE (trofinetide) approval for the treatment of Rett syndrome in adults and children over the age of two last Friday. DAYBUE is the first and only medication approved for the treatment of Rett syndrome. Acadia and the Rett community have reached a significant turning point today. Steve Davis, CEO […]

Continue Reading

Acadia Healthcare Partners with Bronson Healthcare to Build New Hospital in Michigan

Sandy B

On Wednesday, 30th June 2021, the companies Acadia Healthcare and Bronson Healthcare announce, they have successfully formed a joint venture for the purpose of building a behavioral health facility, which will have 96 beds in the region of Battle Creek, Michigan, US. Together Both, Acadia Healthcare and Bronson Healthcare are going to construct, develop and […]

Continue Reading